Lv3
236 积分 2025-08-30 加入
A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered SRSD107 in Healthy Subjects
6天前
已关闭
KN060-a humanized dual-domain antibody simultaneously targeting FXI-A2/A3 epitopes: Pioneering the anti-coagulation factor XI strategy for Aterial hypertension – Evidence from preclinical models
7天前
已完结
中国临床血脂检测指南（2026版）
1个月前
已完结
Global Epidemiology of Hyperuricemia: An Analysis of Trends Over the Past Decade
2个月前
已完结
奥赛利定治疗全麻患者术后中重度疼痛的有效性和安全性：随机、盲法、阳性对照、多中心临床试验
4个月前
已完结
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050
4个月前
已完结
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050
5个月前
已完结
[Annual review of bronchiectasis 2024]
1年前
已完结
Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
1年前
已完结
皖公网安备34019202002308
